You have 9 free searches left this month | for more free features.

clofarabine

Showing 1 - 25 of 116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Antithymocyte Globulin
  • Clofarabine
  • Boston, Massachusetts
  • +1 more
Jan 25, 2022

Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

Completed
  • Hematologic Malignancies
  • +7 more
  • Clofarabine
  • Fludarabine Injection
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,

Terminated
  • Minimal Residual Disease
  • +2 more
  • Clofarabine
  • +3 more
  • Charlotte, North Carolina
  • +1 more
Oct 4, 2021

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Clofarabine
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • clofarabine
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Sep 21, 2021

Langerhans Cell Histiocytosis Trial in Canada, United States (Clofarabine)

Active, not recruiting
  • Langerhans Cell Histiocytosis
  • Clofarabine
  • Phoenix, Arizona
  • +14 more
Mar 28, 2022

Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

Completed
  • Acute Myeloid Leukemia
  • Palo Alto, California
  • +7 more
Aug 6, 2021

Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Pediatric Cancer
  • Boston, Massachusetts
  • +1 more
Oct 24, 2022

Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)

Terminated
  • Acute Lymphoblastic Leukemia
  • Alemtuzumab
  • Clofarabine
  • La Jolla, California
  • +2 more
Jul 29, 2020

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Clofarabine
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)

Completed
  • Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2020

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • Clofarabine
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Clofarabine
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Lymphoma Trial in Portland (biological, drug, genetic, other)

Terminated
  • Lymphoma
  • rituximab
  • +7 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Nov 15, 2019

Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases Trial run by the NHLBI (Clofarabine,

Completed
  • Myeldysplastic Syndrome (MDS)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia Trial in Columbus, Madison, Milwaukee (Clofarabine, Cyclophosphamide,

Terminated
  • Leukemia, Acute Lymphoblastic
  • Acute Myeloid Leukemia
  • Clofarabine
  • +2 more
  • Columbus, Ohio
  • +3 more
Feb 18, 2020

Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)

Completed
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +3 more
Apr 3, 2020

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Clofarabine
  • +2 more
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

Terminated
  • Non-Malignant Hematologic Disorders
  • New York, New York
    Memorial SloanKettering Cancer Center
Mar 1, 2021